Paper21973
Protective efficacy of pneumococcal polysaccharide vaccines.
Smit P and 4 others. JAMA, 1977. Cited by 323 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Protective efficacy of pneumococcal polysaccharide vaccines. Papers, record 21973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21973
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Vaccines | Major topic |
| Pneumococcal Infections | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Streptococcus pneumoniae | Major topic |
| Adult | |
| Antibody Formation | |
| Clinical Trials as Topic | |
| Gold | |
| Humans | |
| Male | |
| Mining | |
| Neisseria meningitidis | |
| Occupational Diseases | |
| South Africa |
Source PubMed
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 323 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,511,672 | Isohemagglutinins exhibit synergistic polyreactivity toward Streptococcus pneumoniae surface antigens: implications for broad-spectrum reactivity of human antibodies. | Med Microbiol Immunol | 2026 | https://conductscience.org/library/papers/41511672 | PubMed |
| 40,872,951 | Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Chinese Children, Adults and the Elderly: A Phase 4, Randomized, Double-Blind, Active-Controlled Clinical Trial. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40872951 | PubMed |
| 39,012,111 | Upper respiratory Streptococcus pneumoniae colonization among working-age adults with prevalent exposure to overcrowding. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/39012111 | PubMed |
| 38,620,135 | [Guidelines for the management of community pneumonia in adult who needs hospitalization]. | Med Intensiva | 2005 | https://conductscience.org/library/papers/38620135 | PubMed |
| 36,324,501 | Applying differential network analysis to longitudinal gene expression in response to perturbations. | Front Genet | 2022 | https://conductscience.org/library/papers/36324501 | PubMed |
| 36,153,636 | The remarkable history of pneumococcal vaccination: an ongoing challenge. | Pneumonia (Nathan) | 2022 | https://conductscience.org/library/papers/36153636 | PubMed |
| 35,862,754 | Controlled Human Infection Models To Accelerate Vaccine Development. | Clin Microbiol Rev | 2022 | https://conductscience.org/library/papers/35862754 | PubMed |
| 34,019,468 | Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older. | Hum Vaccin Immunother | 2021 | https://conductscience.org/library/papers/34019468 | PubMed |
| 33,340,093 | The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity. | Immunology | 2021 | https://conductscience.org/library/papers/33340093 | PubMed |
| 32,024,194 | Characterizing the Physical Properties and Cell Compatibility of Phytoglycogen Extracted from Different Sweet Corn Varieties. | Molecules | 2020 | https://conductscience.org/library/papers/32024194 | PubMed |
| 30,881,363 | Mechanisms of Naturally Acquired Immunity to Streptococcus pneumoniae. | Front Immunol | 2019 | https://conductscience.org/library/papers/30881363 | PubMed |
| 30,143,807 | Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines. | Adv Biochem Eng Biotechnol | 2021 | https://conductscience.org/library/papers/30143807 | PubMed |
| 29,988,379 | Streptococcus pneumoniae's Virulence and Host Immunity: Aging, Diagnostics, and Prevention. | Front Immunol | 2018 | https://conductscience.org/library/papers/29988379 | PubMed |
| 28,135,322 | Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens. | PLoS Pathog | 2017 | https://conductscience.org/library/papers/28135322 | PubMed |
| 28,116,747 | Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28116747 | PubMed |
| 28,061,505 | Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. | PLoS One | 2017 | https://conductscience.org/library/papers/28061505 | PubMed |
| 27,398,741 | What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults? | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27398741 | PubMed |
| 27,149,114 | Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27149114 | PubMed |
| 27,002,793 | Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27002793 | PubMed |
| 23,440,780 | Vaccines for preventing pneumococcal infection in adults. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23440780 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21973
GET https://conductscience.org/api/papers/v1/21973/cited_by?page=2